Pulmatrix Inc (PULM)
1.86
-0.10
(-5.10%)
USD |
NASDAQ |
May 06, 16:00
1.85
-0.01
(-0.54%)
After-Hours: 06:08
Pulmatrix Cash from Operations (TTM): -15.98M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -15.98M |
September 30, 2023 | -19.02M |
June 30, 2023 | -18.48M |
March 31, 2023 | -18.14M |
December 31, 2022 | -19.36M |
September 30, 2022 | -18.71M |
June 30, 2022 | -18.41M |
March 31, 2022 | -20.38M |
December 31, 2021 | -19.73M |
September 30, 2021 | -18.10M |
June 30, 2021 | -20.30M |
March 31, 2021 | -18.78M |
December 31, 2020 | -12.48M |
September 30, 2020 | -14.15M |
June 30, 2020 | -12.56M |
March 31, 2020 | 7.484M |
December 31, 2019 | 3.23M |
September 30, 2019 | 3.498M |
June 30, 2019 | 2.905M |
March 31, 2019 | -17.09M |
December 31, 2018 | -16.76M |
September 30, 2018 | -15.81M |
Date | Value |
---|---|
June 30, 2018 | -15.90M |
March 31, 2018 | -14.61M |
December 31, 2017 | -14.48M |
September 30, 2017 | -13.77M |
June 30, 2017 | -11.95M |
March 31, 2017 | -12.16M |
December 31, 2016 | -13.24M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | -5.386M |
December 31, 2014 | -5.619M |
September 30, 2014 | -4.53M |
June 30, 2014 | -4.278M |
March 31, 2014 | -2.969M |
December 31, 2013 | -1.937M |
September 30, 2013 | -1.753M |
June 30, 2013 | -0.742M |
March 31, 2013 | -0.426M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-20.38M
Minimum
Mar 2022
7.484M
Maximum
Mar 2020
-13.02M
Average
-18.14M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Oragenics Inc | -7.291M |